Both international and local pharmaceutical and medical device company in China have marked the continuously recorded growth with double digits. However with the current trends of increasing local and foreign competition, coming expirations of best selling products, rare approvable of new molecules, cost-saving by outsourcing research and development, access to innovative technology and low productivity/ROI of sale force through a non-synergy product portfolio which created the demand for licensing- in/acquisition of innovative and generic products.
Loudon with local networks of 16 years experience provide Licensing-in/out services for pharmaceutical and medical device company as following:
Loudon China has established following licensing assets for distribution negotiation in China,
| TA | Categories | |
| Antiallergic | Medicine | |
| Anti-infection | Medicine | |
| Obesity | Medicine | |
| Respiratory | Medicine | |
| Cardiovascular | Medicine | |
| Endocrinology | Medicine | |
| Gastrointestinal | Medicine | |
| Psychiatric | Medicine | |
| Neurology | Medicine | |
| Pediatrics | Medical Device |
Here is the detail list of imported products open for further licensing discussions.
Please fill the application form if you are interested of discussing the above products for licensing in Great China
Any questions, pls contact us through Jenny.zhu@loudon-research.com.